UBS Group’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186M | Buy |
1,467,367
+52,237
| +4% | +$6.61M | 0.03% | 467 |
|
|
2025
Q1 | $181M | Buy |
1,415,130
+313,404
| +28% | +$40.1M | 0.03% | 462 |
|
|
2024
Q4 | $146M | Buy |
1,101,726
+223,227
| +25% | +$29.5M | 0.03% | 538 |
|
|
2024
Q3 | $128M | Sell |
878,499
-27,111
| -3% | -$3.95M | 0.03% | 454 |
|
|
2024
Q2 | $124M | Sell |
905,610
-530,425
| -37% | -$72.8M | 0.03% | 426 |
|
|
2024
Q1 | $197M | Buy |
1,436,035
+118,886
| +9% | +$16.3M | 0.05% | 287 |
|
|
2023
Q4 | $179M | Sell |
1,317,149
-103,434
| -7% | -$14.1M | 0.05% | 261 |
|
|
2023
Q3 | $174M | Sell |
1,420,583
-120,951
| -8% | -$14.8M | 0.06% | 245 |
|
|
2023
Q2 | $196M | Buy |
1,541,534
+181,338
| +13% | +$23M | 0.07% | 227 |
|
|
2023
Q1 | $176M | Sell |
1,360,196
-107,646
| -7% | -$13.9M | 0.06% | 235 |
|
|
2022
Q4 | $193M | Sell |
1,467,842
-68,282
| -4% | -$8.96M | 0.07% | 223 |
|
|
2022
Q3 | $180M | Sell |
1,536,124
-417,142
| -21% | -$48.8M | 0.08% | 209 |
|
|
2022
Q2 | $230M | Sell |
1,953,266
-52,530
| -3% | -$6.18M | 0.09% | 187 |
|
|
2022
Q1 | $261M | Buy |
2,005,796
+146,343
| +8% | +$19.1M | 0.09% | 188 |
|
|
2021
Q4 | $284M | Sell |
1,859,453
-78,580
| -4% | -$12M | 0.08% | 179 |
|
|
2021
Q3 | $313M | Sell |
1,938,033
-371,200
| -16% | -$60M | 0.1% | 162 |
|
|
2021
Q2 | $378M | Buy |
2,309,233
+87,588
| +4% | +$14.3M | 0.12% | 132 |
|
|
2021
Q1 | $334M | Sell |
2,221,645
-17,046
| -0.8% | -$2.57M | 0.11% | 146 |
|
|
2020
Q4 | $339M | Sell |
2,238,691
-3,654
| -0.2% | -$554K | 0.11% | 148 |
|
|
2020
Q3 | $304M | Sell |
2,242,345
-123,858
| -5% | -$16.8M | 0.11% | 147 |
|
|
2020
Q2 | $323M | Buy |
2,366,203
+535,280
| +29% | +$73.2M | 0.14% | 130 |
|
|
2020
Q1 | $197M | Sell |
1,830,923
-269,137
| -13% | -$29M | 0.09% | 171 |
|
|
2019
Q4 | $253M | Sell |
2,100,060
-34,370
| -2% | -$4.14M | 0.09% | 173 |
|
|
2019
Q3 | $212M | Sell |
2,134,430
-3,626,524
| -63% | -$361M | 0.08% | 190 |
|
|
2019
Q2 | $629M | Buy |
5,760,954
+1,679,761
| +41% | +$183M | 0.24% | 79 |
|
|
2019
Q1 | $456M | Buy |
4,081,193
+854,906
| +26% | +$95.6M | 0.19% | 111 |
|
|
2018
Q4 | $311M | Sell |
3,226,287
-382,189
| -11% | -$36.9M | 0.14% | 134 |
|
|
2018
Q3 | $440M | Sell |
3,608,476
-861,112
| -19% | -$105M | 0.17% | 115 |
|
|
2018
Q2 | $491M | Buy |
4,469,588
+1,537,624
| +52% | +$169M | 0.21% | 95 |
|
|
2018
Q1 | $313M | Buy |
2,931,964
+97,678
| +3% | +$10.4M | 0.14% | 141 |
|
|
2017
Q4 | $303M | Buy |
2,834,286
+2,246,299
| +382% | +$240M | 0.12% | 147 |
|
|
2017
Q3 | $196M | Sell |
587,987
-19,447
| -3% | -$6.49M | 0.09% | 177 |
|
|
2017
Q2 | $188M | Sell |
607,434
-106,676
| -15% | -$33.1M | 0.1% | 179 |
|
|
2017
Q1 | $209M | Buy |
714,110
+50,098
| +8% | +$14.7M | 0.11% | 170 |
|
|
2016
Q4 | $176M | Buy |
664,012
+165,247
| +33% | +$43.9M | 0.1% | 185 |
|
|
2016
Q3 | $144M | Sell |
498,765
-52,084
| -9% | -$15.1M | 0.09% | 210 |
|
|
2016
Q2 | $142M | Buy |
550,849
+88,544
| +19% | +$22.8M | 0.09% | 204 |
|
|
2016
Q1 | $121M | Sell |
462,305
-263,759
| -36% | -$68.8M | 0.08% | 219 |
|
|
2015
Q4 | $246M | Sell |
726,064
-306,010
| -30% | -$104M | 0.16% | 125 |
|
|
2015
Q3 | $313M | Buy |
1,032,074
+210,378
| +26% | +$63.8M | 0.22% | 85 |
|
|
2015
Q2 | $303M | Buy |
821,696
+5,441
| +0.7% | +$2.01M | 0.2% | 98 |
|
|
2015
Q1 | $280M | Sell |
816,255
-373,652
| -31% | -$128M | 0.19% | 108 |
|
|
2014
Q4 | $361M | Buy |
+1,189,907
| New | +$361M | 0.25% | 69 |
|